Is hypertriglyceridemia a reliable indicator of cholesterol-depleted apoB particles?

Because cholesterol-depleted apoB particles are thought to be a hallmark of hypertriglyceridemia, American, Canadian and European Lipid Guidelines suggest screening for apoB only in patients with hypertriglyceridemia. Accordingly, this study examines the relationship of triglycerides to the LDL-C/ap...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical lipidology
Main Authors De Marco, Davide, Pencina, Karol, Pencina, Michael, Dufresne, Line, Thanassoulis, George, Sniderman, Allan D
Format Journal Article
LanguageEnglish
Published United States 12.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Because cholesterol-depleted apoB particles are thought to be a hallmark of hypertriglyceridemia, American, Canadian and European Lipid Guidelines suggest screening for apoB only in patients with hypertriglyceridemia. Accordingly, this study examines the relationship of triglycerides to the LDL-C/apoB and non-HDL-C/apoB ratios. METHODS: The study cohort consisted of 6272 NHANES subjects adjusted for a weighted sample size of 150 million subjects without previously diagnosed cardiac disease. Data was reported by LDL-C/apoB tertiles as weighted frequencies and percent. Sensitivity, specificity, negative predictive and positive predictive values were calculated for triglycerides thresholds of >150 mg/dL and >200 mg/dL. The range of values of apoB for decisional levels of LDL-C and non-HDL-C were also determined RESULTS: Among patients with triglycerides >200 mg/dL, 75.9% were amongst the lowest LDL-C/apoB tertile. However, this represents only 7.5% of the total population. Of patients with the lowest LDL-C/apoB ratio, 59.8% had triglycerides <150mg/dL. Moreover, there was an inverse relationship between non-HDL-C/apoB such that elevated triglycerides were associated with the highest tertile of non-HDL-C/apoB. Finally, the range of values of apoB for decisional levels of LDL-C and non-HDL-C was determined and is so broad- 30.3-40.6 mg/dl apoB for different levels of LDL-C and 19.5 to 27.6 mg/dl apoB for different levels of non-HDL-C- that neither is an adequate clinical surrogate for apoB. CONCLUSION: Plasma triglycerides should not be used to restrict the measurement of apoB since cholesterol-depleted apoB particles may be present at any level of triglyceride.
AbstractList Because cholesterol-depleted apoB particles are thought to be a hallmark of hypertriglyceridemia, American, Canadian and European Lipid Guidelines suggest screening for apoB only in patients with hypertriglyceridemia. Accordingly, this study examines the relationship of triglycerides to the LDL-C/apoB and non-HDL-C/apoB ratios. METHODS: The study cohort consisted of 6272 NHANES subjects adjusted for a weighted sample size of 150 million subjects without previously diagnosed cardiac disease. Data was reported by LDL-C/apoB tertiles as weighted frequencies and percent. Sensitivity, specificity, negative predictive and positive predictive values were calculated for triglycerides thresholds of >150 mg/dL and >200 mg/dL. The range of values of apoB for decisional levels of LDL-C and non-HDL-C were also determined RESULTS: Among patients with triglycerides >200 mg/dL, 75.9% were amongst the lowest LDL-C/apoB tertile. However, this represents only 7.5% of the total population. Of patients with the lowest LDL-C/apoB ratio, 59.8% had triglycerides <150mg/dL. Moreover, there was an inverse relationship between non-HDL-C/apoB such that elevated triglycerides were associated with the highest tertile of non-HDL-C/apoB. Finally, the range of values of apoB for decisional levels of LDL-C and non-HDL-C was determined and is so broad- 30.3-40.6 mg/dl apoB for different levels of LDL-C and 19.5 to 27.6 mg/dl apoB for different levels of non-HDL-C- that neither is an adequate clinical surrogate for apoB. CONCLUSION: Plasma triglycerides should not be used to restrict the measurement of apoB since cholesterol-depleted apoB particles may be present at any level of triglyceride.
Author Pencina, Karol
Sniderman, Allan D
Pencina, Michael
De Marco, Davide
Thanassoulis, George
Dufresne, Line
Author_xml – sequence: 1
  givenname: Davide
  surname: De Marco
  fullname: De Marco, Davide
  organization: Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Royal Victoria Hospital, Glen Site - C04.4180, 1001 Boulevard Décarie, Montreal, Quebec H4A 3J1, Canada
– sequence: 2
  givenname: Karol
  surname: Pencina
  fullname: Pencina, Karol
  organization: Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
– sequence: 3
  givenname: Michael
  surname: Pencina
  fullname: Pencina, Michael
  organization: Duke University School of Medicine, Biostatistics and Bioinformatics, DCRI, Durham, NC, United Kingdom
– sequence: 4
  givenname: Line
  surname: Dufresne
  fullname: Dufresne, Line
  organization: Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Royal Victoria Hospital, Glen Site - C04.4180, 1001 Boulevard Décarie, Montreal, Quebec H4A 3J1, Canada
– sequence: 5
  givenname: George
  surname: Thanassoulis
  fullname: Thanassoulis, George
  organization: Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Royal Victoria Hospital, Glen Site - C04.4180, 1001 Boulevard Décarie, Montreal, Quebec H4A 3J1, Canada
– sequence: 6
  givenname: Allan D
  surname: Sniderman
  fullname: Sniderman, Allan D
  email: allan.sniderman@mcgill.ca
  organization: Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Royal Victoria Hospital, Glen Site - C04.4180, 1001 Boulevard Décarie, Montreal, Quebec H4A 3J1, Canada. Electronic address: allan.sniderman@mcgill.ca
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37225542$$D View this record in MEDLINE/PubMed
BookMark eNqFjrEOgjAUADtgBNRfMP0BEmxp0MlEo9GdnZT2ITWFNq914O910NnphrvhcpJMboKEZLsD5wXb11VK8hCeZSlEXYolSXnNmBAVy0hzD3SYPWBE87CzAjQaRiOppAjWyM4CNZM2SkaH1PVUDc5CiIDOFhq8hQiaSu9O1EuMRn3kcU0WvbQBNl-uyPZ6ac63wr-6EXTr0YwS5_a3wf8Gb5l0QD4
ContentType Journal Article
Copyright Copyright © 2023. Published by Elsevier Inc.
Copyright_xml – notice: Copyright © 2023. Published by Elsevier Inc.
DBID NPM
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 37225542
Genre Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXKI
AAXUO
ABBQC
ABJNI
ABMAC
ABMZM
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
J1W
KOM
M41
MO0
N9A
NPM
O-L
O9-
OA.
OAUVE
OL~
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SEL
SES
SPCBC
SSH
SSZ
T5K
Z5R
~G-
ID FETCH-pubmed_primary_372255423
ISSN 1933-2874
IngestDate Sat Sep 28 08:19:01 EDT 2024
IsPeerReviewed true
IsScholarly true
Keywords Triglycerides
LDL-C/apoB ratio, Small dense LDL
Guidelines
apoB
Language English
License Copyright © 2023. Published by Elsevier Inc.
LinkModel OpenURL
MergedId FETCHMERGED-pubmed_primary_372255423
PMID 37225542
ParticipantIDs pubmed_primary_37225542
PublicationCentury 2000
PublicationDate 2023-May-12
PublicationDateYYYYMMDD 2023-05-12
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-May-12
  day: 12
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of clinical lipidology
PublicationTitleAlternate J Clin Lipidol
PublicationYear 2023
SSID ssj0055705
Score 4.7105455
Snippet Because cholesterol-depleted apoB particles are thought to be a hallmark of hypertriglyceridemia, American, Canadian and European Lipid Guidelines suggest...
SourceID pubmed
SourceType Index Database
Title Is hypertriglyceridemia a reliable indicator of cholesterol-depleted apoB particles?
URI https://www.ncbi.nlm.nih.gov/pubmed/37225542
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JasMwEBVNCiWX0tJ9CTr0FlycWIqTU0k3ki45pZBbkCWZGlzb2O6h_fqO5HhJcKDtRRgJy2IeyDOj90YIXbmCWsQVxHAce2gQ4vQM1rddlbeyGDcH3CJKnPw67Y_fyNOczsv7HLW6JHWu-XetruQ_qEIf4KpUsn9AtpgUOuAZ8IUWEIb2VxhPks47xJFxCiG2_8Xhk4rrzjpMSVQ8LYpSR9JcBdaaP64uw1WVEULfEDICyMDdZFF424lKgtwK0a_irxYaSt-LPLGSjb9XFxjFPCxI8rLccQPuFbKz0K_prxL3tUftxjLJ8qwv-aH_Mi3R0yTAbiVTCY6hZahi-tV9GswXfWgwLBs2EpoV1loreJ0PNVDD6tIm2h5NnsfT_PeqSobRjCqQzd9CO_kba6GBdhFme2h3aSs8yky5j7ZkcIBmkwTXgYQZzkHCBUg4dHEdSFiBhAuQbg5R-_Fhdjc2soUsoqxmyCJfonWEmkEYyBOEqbRN4YJ_zohLVNjXNflAUiFsszcUJj9FxxsmOds4co5aJRgXqJnGn_ISvKbUaS_t-ANE4yK7
link.rule.ids 315,783,787
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+hypertriglyceridemia+a+reliable+indicator+of+cholesterol-depleted+apoB+particles%3F&rft.jtitle=Journal+of+clinical+lipidology&rft.au=De+Marco%2C+Davide&rft.au=Pencina%2C+Karol&rft.au=Pencina%2C+Michael&rft.au=Dufresne%2C+Line&rft.date=2023-05-12&rft.issn=1933-2874&rft_id=info%3Apmid%2F37225542&rft.externalDocID=37225542
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1933-2874&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1933-2874&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1933-2874&client=summon